Alan W. Stitt
About
In The Last Decade
Alan W. Stitt
229 papers receiving 14.2k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Ophthalmology 5.8k
- Molecular Biology 5.3k
- Clinical Biochemistry 3.6k
- Radiology, Nuclear Medicine and Imaging 3.2k
- Endocrinology, Diabetes and Metabolism 1.7k
Countries citing papers authored by Alan W. Stitt
This map shows the geographic impact of Alan W. Stitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan W. Stitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan W. Stitt more than expected).
Fields of papers citing papers by Alan W. Stitt
This network shows the impact of papers produced by Alan W. Stitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan W. Stitt. The network helps show where Alan W. Stitt may publish in the future.
Co-authorship network of co-authors of Alan W. Stitt
This figure shows the co-authorship network connecting the top 25 collaborators of Alan W. Stitt. A scholar is included among the top collaborators of Alan W. Stitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan W. Stitt. Alan W. Stitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 11 | |
| 6 | 16 | |
| 7 | 9 | |
| 8 | 20 | |
| 9 | Pre-treatment of Endothelial Colony Forming Cells (ECFCs) with a novel anti-oxidant enhances their vasoregenerative potential. | 1 |
| 10 | Lp-PLA 2 is a potential therapeutic target in diabetic macula edema | 2 |
| 11 | A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair | 1 |
| 12 | Prediction of Heart Failure Mortality in Emergent Care | 3 |
| 13 | Secretion Of Vascular Growth Factors/inflammatory Cytokines By Rpe Is Inhibited By Ranibizumab | 0 |
| 14 | Fluctuating Levels Of Circulating VEGF In A Subset Of Patients As Part Of The Multicentre IVAN Study | 1 |
| 15 | Proteomic Analysis of Advanced Glycation End-Product (Age) Modified Proteins in High Glucose-Exposed Retinal Müller Glia: Evidence for Age-Mediated Cell Dysfunction During Diabetic Retinopathy | 1 |
| 16 | Advanced Glycation End Products (AGEs) accumulate in the Reproductive Tract of Men with Diabetes. | 1 |
| 17 | Ocular wounding prevents pre-retinal neovascularization and upregulates PEDF expression in the inner retina. | 17 |
| 18 | Effects of Endostatin, Placental Growth Factor and Vascular Endothelial Growth Factor on Blood Retinal Barrier Function | 0 |
| 19 | A Modulatory Role for Advanced Glycation End-Products (AGEs) in Retinal Microvascular Leukostasis | 3 |
| 20 | Low expression of AGE-receptor-1 in NOD mouse mesangial cells: Possible link to diabetic nephropathy. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.